Skip to main content

Calcinosis in Dermatomyositis

  • Chapter
Dermatomyositis

Calcinosis is a distressing late complication of juvenile DM [1, 2], but may appear early in the disease course [3] or be a consequence of externed therapy with corticosteroids [1, 4]. It may be expected in most long-term survivors of juvenile DM [1], but it occurs also in adults [5]. Calcinosis occurs in 30% [6] to 70% [7] of juvenile DM, and is two to three times more common than in adult DM [8]. In a large retrospective study was found cutaneous calcification in 20% of adults and 74% of children [9]. Approximately 25% of juvenile-onset classic DM patients have dystrophic calcification at the time of diagnosis, and 40–50% develop calcinosis sometime during the course of their disease [10]. Calcinosis is a late manifestation, with average duration of the disease in adults being 3.8 years prior to the clinical diagnosis. In both children and adults, the severity of calcinosis often correlates with the level of long-term disability [1]. It is usually a sign of “burned-out” myositis; it contributes to muscle atrophy and joint contractures [11]. Cutaneous calcinosis in DM usually appears between 4 months and 12 years after the onset of the disease, with an average time interval of 2–5 years between the disease onset and calcium deposition [8]. Calcium deposit in the skin is a common cause of cutaneous ulceration [11] and sterile necrotic abcesses [12].

Calcification associated with DM has been categorized into five different subtypes: (i) superficial calcifications present as small and hard plaques or nodules that can be felt just below the skin surface, (ii) subcutaneous calcifications—large tumorous deposits of calcium, which often appear “popcorn-like” on X-ray examination, (iii) intermuscular calcifications—deposits in the intermuscular fascia with limitation of movement in the involved muscle group, (iv) dystrophic calcification—a severe form, which resembles an exoskeleton, (v) a mixed form of calcinosis [1], and (vi) calcinosis universalis, which is loosely defined as numerous large deposits of calcium in the skin, subcutaneous tissue, muscles, and tendons [13]. Calcification of the muscles is generally asymptomatic, and may be seen only on radiological assesment [14]. Bone resorption markers, serum ionized Ca and urinary Ca levels point to the increased bone turnover and reduced excretion in patients with extensive calcinosis [15]. Complete regression of calcium deposits is not usually expected except in the first subtype [2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 149.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Bowyer SL, Blane CE, Sullivan DB, et al. Chilhood dermatomyositis factors predicting functional outcome and development of dystrophic calcification. J Pediatr 1983; 103: 882–888.

    Article  PubMed  CAS  Google Scholar 

  2. Ichiki Y, Akiyama T, Shimozawa N, et al. An extremely severe case of cutaneous calcinosis with juvenile dermatomyositis, and successful treatment with diltiazem. Br J Dermatol 2001; 144: 894–897.

    Article  PubMed  CAS  Google Scholar 

  3. Pachman LM, Cooke N. Juvenile dermatomyositis: a clinical and immunologic study. J Pediatr 1980; 96: 226–234.

    Article  PubMed  CAS  Google Scholar 

  4. Miller G, Heckmatt JZ, Dubowitz V. Drug treatment of juvenile dermatomyositis. Arch Dis Child 1983; 58: 445–450.

    Article  PubMed  CAS  Google Scholar 

  5. Dasgeb B, Phillips TJ. Adult-onset dermatomyositis complicated by calcinosis cutis. Wounds 2004; 16(12): 364–370.

    Google Scholar 

  6. Pachman LM, Friedman JM, Maryjowski-Sweeney ML, et al. Immunogenetic studies of juvenile dermatomyositis. III. Study of antibody to organ-specific and nuclear antigens. Arthritis Rheum 1985; 28(2): 151–157.

    Article  PubMed  CAS  Google Scholar 

  7. Bowyer SL, Clark RAF, Ragsdale CG, et al. Juvenile dermatomyositis: histological findings and pathogenic hypothesis for the associated skin changes. J Rheumatol 1986; 13: 753–758.

    PubMed  CAS  Google Scholar 

  8. Wananukul S, Pongprasit P, Wattanakrai P. Calcinosis cutis presenting years before other clinical manifestations of juvenile dermatomyositis: report of two cases. Aust J Dermatol 1997; 38: 202–205.

    Article  CAS  Google Scholar 

  9. Muller SA, Winkelmann RK, Brunsting LA. Calcinosis in dermatomyositis. Arch Dermatol 1959; 79: 669–673.

    CAS  Google Scholar 

  10. Sontheimer RD. Dermatomyositis: an overview of recent progress with emphasasis on dermatologic aspects. Dermatol Clin 2002; 20: 387–408.

    Article  PubMed  Google Scholar 

  11. Sewell JR, Liyanage B, Ansell BM. Calcinosis in juvenile dermatomyositis. Skeletal Radiol 1978; 3: 137–143.

    Google Scholar 

  12. Wedgewood RJ, Cook CD, Cohen J. Dermatomyositis: report of 26 cases in children with a discussion of endocrine therapy in 13. Pediatrics 1953; 12: 447–466.

    Google Scholar 

  13. Olhoffers IH, Carroll C, Watsky K. Dermatomyositis sine myositis with calcinosis universalis. Br J Dermatol 1999; 141: 365–366.

    Article  Google Scholar 

  14. Callen J P. Dermatomyositis. Lancet 2000; 355: 53–57.

    Article  PubMed  CAS  Google Scholar 

  15. Murphy E, Freaney R, Bresnihan B, et al. Increased bone resorption and failure to respond to antiresorptive therapy in progressive dystrophic calcification. Calcif Tissue Int 2003; 73(5): 433–440.

    Article  PubMed  CAS  Google Scholar 

  16. Dalakas MC. Calcifications in dermatomyositis. N Engl J Med 1995; 333: 978.

    Article  PubMed  CAS  Google Scholar 

  17. Kimball AB, Summers RM, Turner M, et al. Magnetic resonance imaging detection of occult skin and subcutaneous abnormalities in juvenile dermatomyositis: implications for diagnosis and therapy. Arthritis Rheum 2000; 43: 1866–1873.

    Article  PubMed  CAS  Google Scholar 

  18. Halbert AR. Juvenile dermatomyositis. Aust J Dermatol 1996; 37: 106–108.

    Article  CAS  Google Scholar 

  19. Lian J, Pachman L, Gunberg C, et al. Gamma carboxyglutamate excretion and calcinosis in juvenile dermatomyositis. Arthritis Rheum 1982; 25: 1094–1100.

    Article  PubMed  CAS  Google Scholar 

  20. Lian J, Pachman L, Gunberg C, et al. Gamma carboxyglutamate excretion: a marker on patients with ectopic calcification disorders. Arthritis Rheum 1979; 22: 634–635.

    Google Scholar 

  21. Mukamel M, Horev G, Mimouni M. New insight into calcinosis of juvenile dermatomyositis: a study of composition and treatment. J Pediatr 2001; 138(5): 736–766.

    Google Scholar 

  22. Pachman LM, Liotta-Davis MR, Hong DK, et al. TNF-α-308A allele in juvenile dermatomyositis: association with increased production of tumor necrosis factor alpha, disease duration, and pathologic calcifications. Arthritis Rheum 2000; 43: 2368–2377.

    Article  PubMed  CAS  Google Scholar 

  23. Rider L, Ruiz-Hidalgo M, Labora J, et al. Lipodystrophy in juvenile dermatomyositis is associated with calcinosis, but not with hepatocyte differentiation factor DLK levels [abstract]. Arthritis Rheum 2001; 44: S264.

    Google Scholar 

Download references

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

(2009). Calcinosis in Dermatomyositis. In: Dermatomyositis. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-540-79313-7_17

Download citation

  • DOI: https://doi.org/10.1007/978-3-540-79313-7_17

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-79312-0

  • Online ISBN: 978-3-540-79313-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics